A new study has found a dose-dependent relationship between coffee consumption and reduced severity of tremors in men with Parkinson disease.
A new study has found a dose-dependent relationship between coffee consumption and reduced severity of tremors in men with Parkinson disease (PD).
Previous research has established that coffee is a negative risk factor for PD, a neurodegenerative disorder that produces motor symptoms, including tremor, as well as nonmotor symptoms. Based on mouse models, investigators have hypothesized that the caffeine in coffee offsets the loss of striatal dopamine and dopamine transporter binding sites seen in PD. There have been few studies that assessed how coffee consumption may be linked with the motor symptoms of PD, and they have suggested that coffee consumption has a positive effect.
The current study, published in BMC Neurology, aimed to determine the association between coffee drinking and motor symptoms in patients with newly diagnosed PD based on their gender. From 2011 to 2016, the researchers enrolled patients at the Chonnam National University Hospital outpatient clinic in China whose PD had been diagnosed by an expert in movement disorders but not yet treated. They had access to patients’ clinical history and neurological examination results, and they asked participants about their past and present coffee drinking habits in semistructured interviews.
Of the 284 patients enrolled, 71.83% (n = 204) were categorized as coffee drinkers (based on past or current coffee drinking) while 28.17% (n = 80) were considered non—coffee drinkers. There were several significant demographic differences between the groups, including that coffee drinkers tended to be younger than the non–coffee drinkers (mean [SD] age, 64.57 [9.83] vs 68.79 [8.24]; P = .001) and that the group of coffee drinkers had a higher proportion of men (58.8% vs 33.8%; P <.001).
When comparing the participants’ scores on the motor and activities of daily living (ADL) subscales of the Unified Parkinson’s Disease Rating Scale, coffee drinkers had significantly lower overall motor scores and lower tremor, bradykinesia, and gait and posture scores compared with non—coffee drinkers. When examining the type of tremor, only rest tremors, not action tremors, were significantly associated with coffee drinking. This association persisted after adjustment for clinical variables, whereas the other motor scores were no longer significant.
Rest tremor scores were lower in both the male and female subgroups of the coffee drinkers, but when looking for a dose-dependent relationship between coffee and PD symptoms after adjusting for clinical variables, tremor scores were inversely related to the number of cups of coffee per day only in the male subgroup.
The study authors suggested that tremor may be caused by pathophysiological mechanisms that differ from those causing bradykinesia and rigidity, which would help explain why only tremor severity was affected by coffee consumption after adjustment. They called for large prospective studies that could help determine the therapeutic effects of coffee or other adenosine A2A receptor antagonists on symptoms of tremor in patients with PD, as well as studies to elucidate the role of estrogen in modulating the relationship between caffeine and tremor severity in women.
“Further investigations are needed to reveal the exact causal relationship between coffee consumption and tremor in PD patients,” they concluded.
Reference
Cho BH, Choi SM, Kim BC. Gender-dependent effect of coffee consumption on tremor severity in de novo Parkinson’s disease. BMC Neurol. 2019;19(1):194. doi: 10.1186/s12883-019-1427-y.
Major Study Expands in Hopes to Cure Parkinson Disease
April 19th 2022April is Parkinson’s Disease Awareness month, and on this episode of Managed Care Cast, we take a look at the Parkinson's Progression Markers Initiative (PPMI), a study from the Michael J. Fox Foundation for Parkinson's Research (MJFF). The multicenter, international study aims to end Parkinson disease, which is expected to double worldwide by 2040, to more than 14 million people.
Listen
Certain Patient Groups Continue to Be Underrepresented in PD Studies in the Netherlands
February 4th 2023With greater attention being paid to the heterogenous patient population, researchers questioned whether this has resulted in a more diverse group of patients included in Parkinson disease (PD) studies in the Netherlands.
Read More
An Inside Look at Innovations by MJFF to Assist the Parkinson Community Amid the COVID-19 Pandemic
May 26th 2020On this episode of Managed Care Cast, we speak with Rachel Dolhun, MD, vice president of Medical Communications at The Michael J. Fox Foundation for Parkinson Research, about recent innovations by The Michael J. Fox Foundation to assist patients and families of patients with Parkinson disease in adjusting to this new normal.
Listen
Motor Symptoms May Occur 3 Years Before Parkinson Disease Diagnosis, Study Says
January 20th 2023Trouble with balance and holding objects above one's head were just a few of the problems reported by patients 3 years before they received a formal Parkinson disease diagnosis, according to a recent study.
Read More